DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) — KEY investment partners today announced a $1.5 million investment in PHARMACEUTICALRX™, a vertically integrated cannabis operator in the state of Ohio. The investment from KEY is a strong show of confidence in the company’s approach to growing, processing and product development.
PHARMACEUTICALRX (FRX) is the leading organic multi-state vertically integrated operator of medical marijuana in the US market. PHARMACEUTICALRX is focused on bringing research and development-based innovation to the medical marijuana sector. PHARMACEUTICALRX develops premium artisanal and innovative organic products under its existing PHARMACEUTICALRX brand. FARMACEUTICALRX’s Ohio suite of sub-branded products includes Burst of Wellness vape products, TreePharm vape and RSO products, Local Edibles chocolates and confections, CannaRocks sugar-free hard candies and Open Mind organic, vegan and gluten-free gum, the company’s suite of Ohio’s sub-branded products combine the premium organic and artisanal quality that PHARMACEUTICALRX is known for at competitive price points, expanding their reach to a wider patient demographic. FARMACEUTICALRX is led by a world-class team of scientists, healthcare, organic food and beverage and cannabis industry professionals who are driven by the discovery, development and production of premium organic artisan products through a vertically integrated platform with the FARMACEUTICALRX business of Ohio. In addition to KEY’s capital investment, KEY Founding Partner Pete Karabas will join the FRX Board of Directors along with FRX Founder and CEO Rebecca Myers to assist the company with its strategic growth initiatives in 2022. and after this.
“We have been very impressed with Rebecca and her team’s ability to consistently deliver high quality, competitively priced organic cannabis products to medical cannabis patients in the state of Ohio. In the relatively near future, we expect the state to develop a robust recreation program, and we believe FRX will play a key role in the success of that program,” Karabas said.
Using an organic cultivation method called living soil cultivation, FARMACEUTICALRX grows cannabis following traditional organic practices that mimic Mother Nature’s optimal natural conditions to produce premium organic artisan medical marijuana products with each harvest. Plants are cultivated in living soil and environmental conditions are obsessively monitored and controlled. These high standards allow the Company to reliably reproduce the unique genetic profile of each variety to exacting standards, creating consistently high levels of cannabinoids and terpenes with each harvest. The PHARMACEUTICALRX processing team then formulates products with the goal of allowing patients to achieve condition-specific relief, whether that is through live resin and concentrate products, solvent-free products, RSOs, or nutritional products. PHARMACEUTICALRX expects to receive final organic certification in Q4 2022.
“We are extremely pleased with the confidence that KEY Investment Partners has demonstrated through its commitment to our future,” said Rebecca Myers, Founder and CEO of PHARMACEUTICALRX. “The addition of Pete Karabas to our board will be critical as we continue to expand our presence in the state of Ohio.”
KEY Investment Partners continued to deploy capital in the cannabis industry across several different verticals in 2022. Their investment in FRX is a reflection of KEY’s confidence in the continued growth of the cannabis industry even in the midst of difficult macroeconomic times.
About KEY investment partners
Founded in 2018, KEY Investment Partners combines a systematic approach to deal sourcing and rigorous due diligence to connect investors with the most attractive cannabis opportunities. Leveraging decades of combined institutional experience, KEY derives unique opportunities in fast-growing, market-leading cannabis companies that are run by exceptional management teams. The firm uses time-tested methods to provide institutional quality investment management and client service to those seeking to capitalize on the rapid growth of the US cannabis market.
For more information, please visit KEY Investment Partners online or by email [email protected]. Stay informed about investing in cannabis by subscribing to the KEY Investment Partners podcast, Unlocking Cannabis.
PHARMACEUTICALRX is one of the leading producers of premium organic artisan medical marijuana products and the only multi-state, vertically integrated producer of premium organic artisan medical marijuana products in the US market. PHARMACEUTICALRX is focused on bringing research and development-based innovation to the medical marijuana sector. PHARMACEUTICALRX develops premium organic medical marijuana products under its existing PHARMACEUTICALRX brand. The company’s suite of sub-branded products includes Burst of Wellness Vape products, TreePharm Vape and RSO products, Local Edibles chocolates and confections, and Open Mind organic, vegan and gluten-free chewing gum. Our suite of sub-branded products combines the premium quality that PHARMACEUTICALRX is known for at a lower price point to expand the Company’s reach to a wider patient demographic. PHARMACEUTICALRX subsidiaries are licensed to offer premium organic, artisan medical marijuana products in Pennsylvania and Ohio, states with a combined population of more than 26 million people. PHARMACEUTICALRX is led by a world-class team of scientists, healthcare, organic food and beverage and cannabis industry professionals who are driven by the discovery, development and production of revolutionary, premium, organic artisan products delivered through its vertically integrated platform .
From the farm to the future. Learn more at https://farmaceuticalrx.com/.
Contact: Jim Dissett